Julia Levy has been a leader in the fields of science, education, and business. She served first as chief scientific officer and later as chief executive officer of QLT. During her tenure as CEO the company obtained regulatory approval for its macular degeneration treatment that resulted in the financial success of QLT Inc. She is an officer of the Order of Canada and has received a number of honorary degrees.
